Novo Nordisk has slashed its full-year revenue and profit forecasts for the first time since launching its blockbuster weight ...

Gray, or gray market medications, are nothing new, and GLP-1s — the class of weight loss wonder drug that includes ...

With more and more people signing up for weight loss drugs, the potential side effects are starting to attract attention.

Madrigal Pharmaceuticals has a first mover advantage in the huge MASH market due to the approval of Rezdiffra. Read whether I ...

The research involves a thumbnail-sized patch with micro-needles, reportedly so fine they cause no pain or pierce blood vessels, allowing painless drug delivery through skin ...

With pharmaceutical GLP-1 drugs like semaglutide in high demand, Metamorphx offers a plant-based alternative designed to ...

Viking's leading drug candidate could be a blockbuster in the weight loss market, which experts believe could grow to $150 ...

Keeping up with the GLP-1 area is a full-time job by itself. First off, you have the recent development that these drugs are ...

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition ...

The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.

Big pharmaceutical companies as well as smaller biotechs have been hoping to score a win in one of today's highest-growth ...

The Food and Drug Administration had determined there is no longer a shortage of drugs like Ozempic and Wegovy, therefore it had set ending dates for the use of the compounded prescriptions made of ...